Connect with us


Merck Scraps Covid-19 Vaccine Candidates – The Wall Street Journal

The two shots generated comparatively weak immune responses in early-stage studies



post featured image

Merck & Co. said Monday that it is halting development of its two experimental Covid-19 vaccines, after early clinical-trial data showed the shots generated disappointing immune responses against the virus.
Early-stage studies of the vaccines indicated they produced inferior immune responses in subjects given the shots compared with people who survived Covid-19 or took authorized Covid-19 vaccines, the company said.
The exit removes a major vaccine player from the constellation of firms seeking…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
“DC Residents with Qualifying Medical Conditions Can Begin Making Vaccination Appointments Thursday” – PoPville
Article feature image
City takes charge of vaccination sites, eyeing 40,000 in arms this week – Memphis Local, Sports, Business & Food News – The Daily Memphian
Article feature image
UMC registrations for 5,000 vaccinations filled in 3 minutes – KVIA El Paso